Grants and Contributions

About this information

In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.

The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.

Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.

Found 604 records

$50,000.00

Jun 2, 2021

For-profit organization

Agreement:

Production Support Engineer

Agreement Number:

979080

Duration: from Jun 2, 2021 to Mar 31, 2022
Description:

Development and implementation of CANImmunize ClinicFlow to support the COVID-19 vaccine rollout in Canada.

Organization: National Research Council Canada
Program Name: Industrial Research Assistance Program – Youth Employment Program
Location: Nepean, Ontario, CA K2G 1M3

$499,416.00

Jun 1, 2021

Individual or sole proprietorship

Agreement:

Operating Grant: Emerging COVID-19 Research Gaps and Priorities - Vaccines

Agreement Number:

161630

Duration: from Jun 1, 2021 to May 31, 2022
Description:

Please note that to be eligible to the competition applications must address both objectives AND respond to at least one (1) of the fifteen (15) subtopics under the six (6) research areas.
The specific objectives of this funding opportunity are to:
1. Accelerate the availability and use of high-quality and real-time evidence and/or solutions to support Canada’s ongoing response to the pandemic in order to better prevent, detect, treat and manage COVID-19; and inform actions for future pandemic; and
2. Generate evidence related to one or more diverse population(s), including for instance: health equity considerations, health status (e.g. high risk populations, individuals with comorbid conditions), sex and gender, a life cycle approach (from children to aging adults), and/or racialized or First Nations, Inuit, Metis and Urban Indigenous populations.
Note: It is expected that, where appropriate, projects will enhance local, national and/or international collaborative efforts, including in low- and middle-income countries, to mitigate the rapid spread of COVID-19 and related negative consequences.

Organization: Canadian Institutes of Health Research
Program Name: Research in Priority Areas
Location: Toronto, Ontario, CA H3C 3J7

$499,900.00

Jun 1, 2021

Individual or sole proprietorship

Agreement:

Operating Grant: Emerging COVID-19 Research Gaps and Priorities - Vaccines

Agreement Number:

161627

Duration: from Jun 1, 2021 to May 31, 2022
Description:

Please note that to be eligible to the competition applications must address both objectives AND respond to at least one (1) of the fifteen (15) subtopics under the six (6) research areas.
The specific objectives of this funding opportunity are to:
1. Accelerate the availability and use of high-quality and real-time evidence and/or solutions to support Canada’s ongoing response to the pandemic in order to better prevent, detect, treat and manage COVID-19; and inform actions for future pandemic; and
2. Generate evidence related to one or more diverse population(s), including for instance: health equity considerations, health status (e.g. high risk populations, individuals with comorbid conditions), sex and gender, a life cycle approach (from children to aging adults), and/or racialized or First Nations, Inuit, Metis and Urban Indigenous populations.
Note: It is expected that, where appropriate, projects will enhance local, national and/or international collaborative efforts, including in low- and middle-income countries, to mitigate the rapid spread of COVID-19 and related negative consequences.

Organization: Canadian Institutes of Health Research
Program Name: Research in Priority Areas
Location: Saskatoon, Saskatchewan, CA S7N 5A2

$404,547.00

Jun 1, 2021

Individual or sole proprietorship

Agreement:

Operating Grant: Emerging COVID-19 Research Gaps and Priorities - Vaccines

Agreement Number:

161623

Duration: from Jun 1, 2021 to May 31, 2022
Description:

Please note that to be eligible to the competition applications must address both objectives AND respond to at least one (1) of the fifteen (15) subtopics under the six (6) research areas.
The specific objectives of this funding opportunity are to:
1. Accelerate the availability and use of high-quality and real-time evidence and/or solutions to support Canada’s ongoing response to the pandemic in order to better prevent, detect, treat and manage COVID-19; and inform actions for future pandemic; and
2. Generate evidence related to one or more diverse population(s), including for instance: health equity considerations, health status (e.g. high risk populations, individuals with comorbid conditions), sex and gender, a life cycle approach (from children to aging adults), and/or racialized or First Nations, Inuit, Metis and Urban Indigenous populations.
Note: It is expected that, where appropriate, projects will enhance local, national and/or international collaborative efforts, including in low- and middle-income countries, to mitigate the rapid spread of COVID-19 and related negative consequences.

Organization: Canadian Institutes of Health Research
Program Name: Research in Priority Areas
Location: Toronto, Ontario, CA H3C 3J7

$499,800.00

Jun 1, 2021

Individual or sole proprietorship

Agreement:

Operating Grant: Emerging COVID-19 Research Gaps and Priorities - Vaccines

Agreement Number:

161629

Duration: from Jun 1, 2021 to May 31, 2022
Description:

Please note that to be eligible to the competition applications must address both objectives AND respond to at least one (1) of the fifteen (15) subtopics under the six (6) research areas.
The specific objectives of this funding opportunity are to:
1. Accelerate the availability and use of high-quality and real-time evidence and/or solutions to support Canada’s ongoing response to the pandemic in order to better prevent, detect, treat and manage COVID-19; and inform actions for future pandemic; and
2. Generate evidence related to one or more diverse population(s), including for instance: health equity considerations, health status (e.g. high risk populations, individuals with comorbid conditions), sex and gender, a life cycle approach (from children to aging adults), and/or racialized or First Nations, Inuit, Metis and Urban Indigenous populations.
Note: It is expected that, where appropriate, projects will enhance local, national and/or international collaborative efforts, including in low- and middle-income countries, to mitigate the rapid spread of COVID-19 and related negative consequences.

Organization: Canadian Institutes of Health Research
Program Name: Research in Priority Areas
Location: Toronto, Ontario, CA M5G 2C4

$434,655.00

Jun 1, 2021

Individual or sole proprietorship

Agreement:

Operating Grant: Emerging COVID-19 Research Gaps and Priorities - Vaccines

Agreement Number:

161631

Duration: from Jun 1, 2021 to May 31, 2022
Description:

Please note that to be eligible to the competition applications must address both objectives AND respond to at least one (1) of the fifteen (15) subtopics under the six (6) research areas.
The specific objectives of this funding opportunity are to:
1. Accelerate the availability and use of high-quality and real-time evidence and/or solutions to support Canada’s ongoing response to the pandemic in order to better prevent, detect, treat and manage COVID-19; and inform actions for future pandemic; and
2. Generate evidence related to one or more diverse population(s), including for instance: health equity considerations, health status (e.g. high risk populations, individuals with comorbid conditions), sex and gender, a life cycle approach (from children to aging adults), and/or racialized or First Nations, Inuit, Metis and Urban Indigenous populations.
Note: It is expected that, where appropriate, projects will enhance local, national and/or international collaborative efforts, including in low- and middle-income countries, to mitigate the rapid spread of COVID-19 and related negative consequences.

Organization: Canadian Institutes of Health Research
Program Name: Research in Priority Areas
Location: Calgary, Alberta, CA T2N 1N4

$467,999.00

Jun 1, 2021

Individual or sole proprietorship

Agreement:

Operating Grant: Emerging COVID-19 Research Gaps and Priorities - Vaccines

Agreement Number:

162425

Duration: from Jun 1, 2021 to May 31, 2022
Description:

Please note that to be eligible to the competition applications must address both objectives AND respond to at least one (1) of the fifteen (15) subtopics under the six (6) research areas.
The specific objectives of this funding opportunity are to:
1. Accelerate the availability and use of high-quality and real-time evidence and/or solutions to support Canada’s ongoing response to the pandemic in order to better prevent, detect, treat and manage COVID-19; and inform actions for future pandemic; and
2. Generate evidence related to one or more diverse population(s), including for instance: health equity considerations, health status (e.g. high risk populations, individuals with comorbid conditions), sex and gender, a life cycle approach (from children to aging adults), and/or racialized or First Nations, Inuit, Metis and Urban Indigenous populations.
Note: It is expected that, where appropriate, projects will enhance local, national and/or international collaborative efforts, including in low- and middle-income countries, to mitigate the rapid spread of COVID-19 and related negative consequences.

Organization: Canadian Institutes of Health Research
Program Name: Research in Priority Areas
Location: Toronto, Ontario, CA M5G 1X8

$379,900.00

Jun 1, 2021

Individual or sole proprietorship

Agreement:

Operating Grant: Emerging COVID-19 Research Gaps and Priorities - Vaccines

Agreement Number:

161632

Duration: from Jun 1, 2021 to May 31, 2022
Description:

Please note that to be eligible to the competition applications must address both objectives AND respond to at least one (1) of the fifteen (15) subtopics under the six (6) research areas.
The specific objectives of this funding opportunity are to:
1. Accelerate the availability and use of high-quality and real-time evidence and/or solutions to support Canada’s ongoing response to the pandemic in order to better prevent, detect, treat and manage COVID-19; and inform actions for future pandemic; and
2. Generate evidence related to one or more diverse population(s), including for instance: health equity considerations, health status (e.g. high risk populations, individuals with comorbid conditions), sex and gender, a life cycle approach (from children to aging adults), and/or racialized or First Nations, Inuit, Metis and Urban Indigenous populations.
Note: It is expected that, where appropriate, projects will enhance local, national and/or international collaborative efforts, including in low- and middle-income countries, to mitigate the rapid spread of COVID-19 and related negative consequences.

Organization: Canadian Institutes of Health Research
Program Name: Research in Priority Areas
Location: St. John's, Newfoundland & Labrador, CA A1C 5S7

$500,000.00

Jun 1, 2021

Individual or sole proprietorship

Agreement:

Operating Grant: Emerging COVID-19 Research Gaps and Priorities - Vaccines

Agreement Number:

161625

Duration: from Jun 1, 2021 to May 31, 2022
Description:

Please note that to be eligible to the competition applications must address both objectives AND respond to at least one (1) of the fifteen (15) subtopics under the six (6) research areas.
The specific objectives of this funding opportunity are to:
1. Accelerate the availability and use of high-quality and real-time evidence and/or solutions to support Canada’s ongoing response to the pandemic in order to better prevent, detect, treat and manage COVID-19; and inform actions for future pandemic; and
2. Generate evidence related to one or more diverse population(s), including for instance: health equity considerations, health status (e.g. high risk populations, individuals with comorbid conditions), sex and gender, a life cycle approach (from children to aging adults), and/or racialized or First Nations, Inuit, Metis and Urban Indigenous populations.
Note: It is expected that, where appropriate, projects will enhance local, national and/or international collaborative efforts, including in low- and middle-income countries, to mitigate the rapid spread of COVID-19 and related negative consequences.

Organization: Canadian Institutes of Health Research
Program Name: Research in Priority Areas
Location: Ottawa, Ontario, CA K1Y 4E9

$496,871.00

Jun 1, 2021

Individual or sole proprietorship

Agreement:

Operating Grant: Emerging COVID-19 Research Gaps and Priorities - Vaccines

Agreement Number:

161628

Duration: from Jun 1, 2021 to May 31, 2022
Description:

Please note that to be eligible to the competition applications must address both objectives AND respond to at least one (1) of the fifteen (15) subtopics under the six (6) research areas.
The specific objectives of this funding opportunity are to:
1. Accelerate the availability and use of high-quality and real-time evidence and/or solutions to support Canada’s ongoing response to the pandemic in order to better prevent, detect, treat and manage COVID-19; and inform actions for future pandemic; and
2. Generate evidence related to one or more diverse population(s), including for instance: health equity considerations, health status (e.g. high risk populations, individuals with comorbid conditions), sex and gender, a life cycle approach (from children to aging adults), and/or racialized or First Nations, Inuit, Metis and Urban Indigenous populations.
Note: It is expected that, where appropriate, projects will enhance local, national and/or international collaborative efforts, including in low- and middle-income countries, to mitigate the rapid spread of COVID-19 and related negative consequences.

Organization: Canadian Institutes of Health Research
Program Name: Research in Priority Areas
Location: Toronto, Ontario, CA M5B 1W8